[EN] 1,4-DIARYL-DIHYDROPYRIMIDIN-2-ONES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS<br/>[FR] 1,4-DIARYL-DIHYDROPYRIMIDIN-2-ONES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE L'ELASTASE DU NEUTROPHILE HUMAINE
申请人:BAYER HEALTHCARE AG
公开号:WO2005082864A1
公开(公告)日:2005-09-09
The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
Catalytic Kinetic Resolution of Cyclic Secondary Amines
作者:Michael Binanzer、Sheng-Ying Hsieh、Jeffrey W. Bode
DOI:10.1021/ja209472h
日期:2011.12.14
The catalytic resolution of racemic cyclic amines has been achieved by an enantioselective amidation reaction featuring an achiral N-heterocyclic carbene catalyst and a new chiral hydroxamic acid cocatalyst working in concert. The reactions proceed at room temperature, do not generate nonvolatile byproducts, and provide enantioenriched amines by aqueous extraction.
1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors
申请人:Gielen-Haertwig Heike
公开号:US20080064704A1
公开(公告)日:2008-03-13
The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
申请人:Bayer Pharma Aktiengesellschaft
公开号:US08101615B2
公开(公告)日:2012-01-24
The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.